US President Donald Trump's 50% tariff on Indian goods and threats of 250% duties on drugs sparked fears for India's $9.8 billion pharmaceutical exports. US relies on India's generics, but tariffs could raise healthcare costs by $60 billion, hitting patients. India pushed trade talks but No pharmaceutical tariffs have been confirmed yet.